Shawn Cross Applied Molecular Transport Inc. (AMTI) insider trading activity

Shawn Cross is CEO & Chair of the Board of Applied Molecular Transport Inc.. Currently has a direct ownership of 0 shares of AMTI, which is worth approximately $0. The most recent transaction as insider was on Dec 27, 2023, when has been sold 545,499 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Shawn Cross Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 27 2023	SELL Sale (or disposition) back to the issuer	-	545,499 Reduced 100.0%	0 Common Stock
Nov 22 2023	SELL Open market or private sale	$17,728 $0.16 p/Share	110,802 Reduced 16.88%	545,499 Common Stock
Nov 15 2023	SELL Open market or private sale	$14,471 $0.16 p/Share	90,447 Reduced 12.11%	656,301 Common Stock
Sep 29 2023	SELL Open market or private sale	$31,033 $0.16 p/Share	193,960 Reduced 20.5%	752,307 Common Stock
Sep 28 2023	BUY Grant, award, or other acquisition	-	886,111 Added 48.36%	946,267 Common Stock
Sep 05 2023	SELL Open market or private sale	$263 $0.21 p/Share	1,253 Reduced 0.17%	746,748 Common Stock
Jun 02 2023	SELL Open market or private sale	$1,033 $0.24 p/Share	4,306 Reduced 0.57%	748,001 Common Stock
Mar 01 2023	SELL Open market or private sale	$467 $0.5 p/Share	934 Reduced 1.53%	60,156 Common Stock
Dec 02 2022	SELL Open market or private sale	$4,087 $1.05 p/Share	3,893 Reduced 5.99%	61,090 Common Stock
Sep 01 2022	SELL Open market or private sale	$1,255 $1.42 p/Share	884 Reduced 1.34%	64,983 Common Stock
Jun 02 2022	SELL Open market or private sale	$6,585 $3.04 p/Share	2,166 Reduced 3.18%	65,867 Common Stock
Jun 01 2022	SELL Open market or private sale	$5,248 $2.97 p/Share	1,767 Reduced 2.53%	67,983 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	-	18,000 Added 20.51%	69,750 Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	-	20,250 Added 28.13%	51,750 Common Stock
Dec 24 2021	BUY Grant, award, or other acquisition	-	31,500 Added 50.0%	31,500 Common Stock
Aug 23 2021	SELL Open market or private sale	$292,164 $30.12 p/Share	9,700 Reduced 100.0%	0 Common Stock
Aug 23 2021	BUY Exercise of conversion of derivative security	$44,717 $4.61 p/Share	9,700 Added 50.0%	9,700 Common Stock
Aug 19 2021	SELL Open market or private sale	$9,003 $30.01 p/Share	300 Reduced 100.0%	0 Common Stock
Aug 19 2021	BUY Exercise of conversion of derivative security	$1,383 $4.61 p/Share	300 Added 50.0%	300 Common Stock

Also insider at

CYTH

Cyclo Therapeutics, Inc. Healthcare

Director

PCRX

Pacira BioSciences, Inc. Healthcare

Chief Financial Officer

Shawn Cross

CEO & Chair of the Board

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMTI shares.

Notify only if

Value

Insider Trading

Get notified when an Applied Molecular Transport Inc. insider buys or sells AMTI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Applied Molecular Transport Inc.

Track Activities on AMTI

Account